About the UHF Medical Research Competition
The University Hospital Foundation Medical Research Competition (UHFMRC) provides funds to innovative, translational research for clinician scientists in the Faculty of Medicine & Dentistry at the University of Alberta.
Community support of the UHFMRC has contributed more than $6.4 million in seed grants to some 250 peer-reviewed research projects at the University of Alberta Hospital, the Mazankowski Alberta Heart Institute and the Kaye Edmonton Clinic over the past 12 years.
Applications in all areas of biomedical, clinical, health services and outcomes research are acceptable, however a clear linkage to clinical problems in adults is required.
The University Hospital Foundation encourages applications from new investigators – those within five years of their first academic appointment.
Established investigators may apply but are especially encouraged to participate in projects as co-investigator(s)/collaborator(s) with new investigators.
Either the principal investigator or the co-PI are required to hold a primary appointment with Alberta Health Services at the University of Alberta Hospital, Mazankowski Alberta Health Institute, or the Kaye Edmonton Clinic and a faculty appointment with the Faculty of Medicine & Dentistry.
Application and Review Process
Review guidelines to ensure you meet the funding criteria
Registration is mandatory, email the MRC Grant Administrator with the PI, co-PI and co-applicant names and the tentative title of the proposed application by the deadline.
Grant Review Committee reviews and evaluates applications.
Successful applicants invited to submit full applications online and paper copy to the Faculty of Medicine and Dentisry - Office of Research.
2020 winners will be notified by end the of the year.
If you want to move closer to a cure for a complex disease like schizophrenia, you need new ideas. The grant from UHF allowed me to take the research in my lab in a whole new direction.
2019 Award Recipients
Dr. Bo CaoPsychiatry
Prospective prediction of opiod misuse using machine learning
Dr. Matthew CroxenLaboratory Medicine & Pathology
Identification of etiological agent(s) in undiagnosed respiratory infections and microbial encephalitis
Dr. Esme DijkeLaboratory Medicine & Pathology
Immunogenicity of Therapeutic Allogeneic Regulatory T Cells derived from infant human thymus
Dr. Carlos Fernandez-PatronBiochemistry
New proteomics-aided approaches for identifying biomarkers of human pathologies: focus on rheumatoid arthritis
Dr. Nadr JomhaSurgery
Vitrified cartilage transplantation in a porcine model
Dr. Jeremy RempelRadiology & Diagnostic Imaging
A diagnostic technique for assessing reperfusion quality following endovascular thrombectomy
Dr. Oleska RewaCritical Care Medicine
Midodrine for the early weaning from vasopressor support in the ICU - LIBERATE pilot study
Dr. Toru TatenoMedicine
Novel biomarkers for human pituitary tumors
Dr. Toshifumi YokotaMedical Genetics
Identification of novel biomarkers in facioscapulohumeral muscular dystrophy